ObjectivesTo recognize that breast cancer is a heterogeneous disease with different clinical, pathologic andmolecular *** become familiar with the current predictive and prognostic markers for breast *** understand t...
ObjectivesTo recognize that breast cancer is a heterogeneous disease with different clinical, pathologic andmolecular *** become familiar with the current predictive and prognostic markers for breast *** understand the role of the pathologist in the care of breast cancer patients.
Historical Perspectivedescribed gut carcinoid tumor(Langhans *** ***., 38:559-560,1867)describedmicroscopic features of carcinoid tumor(Lubrsh *** *** ***., 111:280-317,1888)described carcinoid syndrome(Ransom ***, 2...
Historical Perspectivedescribed gut carcinoid tumor(Langhans *** ***., 38:559-560,1867)describedmicroscopic features of carcinoid tumor(Lubrsh *** *** ***., 111:280-317,1888)described carcinoid syndrome(Ransom ***, 2:1020-1023,1890)Coined the word 'karzinoide'(Oberndorfer *** Zschr Path., 1:426-430,1907)Recognized as endocrine tumors(Gosset A, masson *** m.d., 25:237-239,1914)
Background to CTCsUnderlying biology of CTCs is poorly understooddemonstration that CTCs above a certain cut-off value are associated with outcome in different malignancies such as breast, lung, prostate, and across ...
Background to CTCsUnderlying biology of CTCs is poorly understooddemonstration that CTCs above a certain cut-off value are associated with outcome in different malignancies such as breast, lung, prostate, and across different platforms suggests some clinical relevance Not all pts with CTCs experience disease relapse, also CTCs may be present many years after initial curative surgery
暂无评论